Viatris
(NASDAQ:VTRS)
11.43
-0.20[-1.72%]
Last update: 2:42PM
15 minutes delayed
Day High/Low11.26 - 11.71
52 Week High/Low9.66 - 15.92
Open / Close11.68 / -
Float / Outstanding1.1B / 1.2B
Vol / Avg.6M / 15.5M
Mkt Cap13.9B
P/E83.07
50d Avg. Price10.74
Div / Yield0.48/4.13%
Payout Ratio321.43
EPS0.33
Total Float1.1B

Viatris (NASDAQ:VTRS), Quotes and News Summary

Viatris (NASDAQ: VTRS)

Day High/Low11.26 - 11.71
52 Week High/Low9.66 - 15.92
Open / Close11.68 / -
Float / Outstanding1.1B / 1.2B
Vol / Avg.6M / 15.5M
Mkt Cap13.9B
P/E83.07
50d Avg. Price10.74
Div / Yield0.48/4.13%
Payout Ratio321.43
EPS0.33
Total Float1.1B
Benzinga - Feb 28, 2022, 3:09PM
load more
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS0.8300.930 0.1000
REV4.230B4.192B-38.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Viatris Questions & Answers

Q
How do I buy Viatris (VTRS) stock?
A

You can purchase shares of Viatris (NASDAQ: VTRS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Viatris's (VTRS) competitors?
A

There are no as such competitors for Viatris.

Q
What is the target price for Viatris (VTRS) stock?
A

The latest price target for Viatris (NASDAQ: VTRS) was reported by Goldman Sachs on Thursday, May 12, 2022. The analyst firm set a price target for 11.00 expecting VTRS to fall to within 12 months (a possible -3.76% downside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Viatris (VTRS)?
A

The stock price for Viatris (NASDAQ: VTRS) is $11.43 last updated Today at May 24, 2022, 6:42 PM UTC.

Q
Does Viatris (VTRS) pay a dividend?
A

A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on June 16, 2022 to stockholders of record on May 23, 2022.

Q
When is Viatris (NASDAQ:VTRS) reporting earnings?
A

Viatris’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Viatris (VTRS) going to split?
A

There is no upcoming split for Viatris.

Q
What sector and industry does Viatris (VTRS) operate in?
A

Viatris is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.